Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 407

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 407
---
 reports, proxy statements and other information with the SEC as required by the Exchange Act. You may access information on Iris at the SEC web site containing reports, proxy statements and other information at: http://www.sec.gov.

If you would like additional copies of this proxy statement/prospectus or if you have questions about the Business Combination, you should contact via phone or in writing:

<div align='center'>Alliance Advisors, LLC 
 200 Broadacres Drive, 3rd Floor 
 Bloomfield, New Jersey 07003 
 Toll Free: 844-670-2141 
 Email: IRAA@allianceadvisors.com</div>

You may also obtain these documents by requesting them via e-mail from IRAA@allianceadvisors.com. If you are a stockholder and would like to request documents, please do so no later than five business days before the Special Meeting in order to receive them before the Special Meeting. If you request any documents from us, we will mail them to you by first class mail, or another equally prompt means.

All information contained in this proxy statement/prospectus relating to Iris has been supplied by Iris, and all such information relating to Liminatus has been supplied by Liminatus. Information provided by either Iris or Liminatus does not constitute any representation, estimate or projection of the other.

This document is a proxy statement of Iris for the Special Meeting. Iris has not authorized anyone to give any information or make any representation about the Business Combination, Iris or Liminatus that is different from or in addition to (and may conflict with) that contained in this proxy statement/prospectus. Therefore, if anyone does give you information of this sort, you should not rely on it. The information contained in this proxy statement/prospectus speaks only as of the date of this document unless the information specifically indicates that another date applies.

<div align='center'>228</div>

TABLE OF CONTENTS

INDEX TO FINANCIAL STATEMENTS

| ​                                                                                                                                      
 Unaudited Financial Statements of Iris Acquisition Corp (formerly known as Tribe Capital Growth Corp I)                                
 Condensed Balance Sheets as of September 30, 2024 and December 31, 2023                                                                
 Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2024 and 2023                                     | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | Page 
 ​    
 ​    
 ​    | ​ 
 ​ 
 ​ | ​    
 F-